Cargando…
The Value of LncRNA BCAR4 as a Prognostic Biomarker on Clinical Outcomes in Human Cancers
Background: This updated meta-analysis aimed to analyze available data to explore the prognostic value of long noncoding RNA breast cancer anti-estrogen resistance 4 (BCAR4) in various human malignancies. Methods: Literature retrieval was performed by systematic searching several authoritative datab...
Autores principales: | Tu, Chao, Ren, Xiaolei, He, Jieyu, Zhang, Chenghao, Chen, Ruiqi, Wang, Wanchun, Li, Zhihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856575/ https://www.ncbi.nlm.nih.gov/pubmed/31762809 http://dx.doi.org/10.7150/jca.35113 |
Ejemplares similares
-
The predictive value of lncRNA MIR31HG expression on clinical outcomes in patients with solid malignant tumors
por: Tu, Chao, et al.
Publicado: (2020) -
The prognostic value of long noncoding RNA SNHG16 on clinical outcomes in human cancers: a systematic review and meta-analysis
por: Zhang, Chenghao, et al.
Publicado: (2019) -
The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis
por: Zhang, Wenchao, et al.
Publicado: (2021) -
Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers
por: Zhang, Chenghao, et al.
Publicado: (2020) -
LncRNA BCAR4 promotes colon cancer progression via activating Wnt/β-catenin signaling
por: Ouyang, Shurui, et al.
Publicado: (2017)